Who owns Solid Biosciences Inc.?
The parent company, the largest shareholders that report their holdings, the funds that own Solid Biosciences Inc. and what its insiders traded, each from the filing that states it.
The short answer
Solid Biosciences Inc. is a listed company: its shares trade on Nasdaq, so it is owned by its shareholders.
158 institutional investors that report to the SEC on Form 13F held 106.5% of its shares on Sep 30, 2026.
The largest of them was Ra Capital Management, L.P. with 10.78%, followed by Perceptive Advisors LLC (10.67%) and Bain Capital Life Sciences Investors, LLC (8.79%).
128 mutual funds held 21.2% of the company in their latest reports (the newest of Jul 31, 2026); the largest position was Vanguard Total Stock Market Index Fund's.
In the last 12 months its insiders reported no purchases and 28 sales worth $3 M on SEC Form 4.
Newest figure: Sep 30, 2026.
Holdings reported on SEC Form 13F for the quarter ended Sep 30, 2026: 158 holders, 106.5% of the shares together.
| # | Holder | Of the shares | Value | Shares | Change in the quarter |
|---|---|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 10.78% | $87 M | 12.0 M | 0.0% |
| 2 | Perceptive Advisors LLC | 10.67% | $86 M | 11.9 M | 0.0% |
| 3 | Bain Capital Life Sciences Investors, LLC | 8.79% | $71 M | 9.8 M | 0.0% |
| 4 | Siren, L.L.C. | 6.89% | $56 M | 7.7 M | 0.0% |
| 5 | FMR LLC | 6.52% | $53 M | 7.3 M | +5.8% |
| 6 | BlackRock, Inc. | 6.12% | $49 M | 6.8 M | -1.4% |
| 7 | RTW Investments, LP | 5.29% | $43 M | 5.9 M | +51.7% |
| 8 | Armistice Capital, LLC | 4.03% | $33 M | 4.5 M | +5.1% |
| 9 | Franklin Templeton Inc | 3.76% | $30 M | 4.2 M | +21.9% |
| 10 | Vanguard Capital Management LLC | 3.56% | $29 M | 4.0 M | -1.1% |
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Filings read up to Nov 17, 2026; the quarter is still being filed (99% of last quarter's holders so far). People who hold shares in their own name, such as founders, are not in 13F reports
How ownership moved#
Institutions held 106.5% of Solid Biosciences Inc. at Sep 30, 2026, down 0.28 points from Jun 30, 2026; 2 more institutions.
| Quarter end | Institutions | Share of the company | Shares bought | Shares sold | Positions opened | Positions closed |
|---|---|---|---|---|---|---|
| Sep 30, 2026(still being filed) | 158 | 106.5% | 10.7 M | 3.5 M | 25 | 25 |
| Jun 30, 2026 | 156 | 106.8% | 24.7 M | 7.7 M | 40 | — |
| Mar 31, 2026 | 141 | 101.5% | — | — | — | — |
| Dec 31, 2025 | 123 | 82.7% | — | — | — | — |
| Sep 30, 2025 | 120 | 104.5% | — | — | — | — |
| Jun 30, 2025 | 110 | 105.6% | — | — | — | — |
| Mar 31, 2025 | 122 | 101.8% | — | — | — | — |
| Dec 31, 2024 | 89 | 46.9% | — | — | — | — |
| Sep 30, 2024 | 91 | 89.7% | — | — | — | — |
| Jun 30, 2024 | 79 | 97.4% | — | — | — | — |
| Mar 31, 2024 | 53 | 92.7% | — | — | — | — |
| Dec 31, 2023 | 37 | 44.0% | — | — | — | — |
| Sep 30, 2023 | 35 | 80.1% | — | — | — | — |
| Jun 30, 2023 | 34 | 81.5% | — | — | — | — |
| Mar 31, 2023 | 37 | 80.6% | — | — | — | — |
| Dec 31, 2022 | 33 | 78.2% | — | — | — | — |
Bought most, quarter to Sep 30, 2026
- RTW Investments, LP+2.0 M
- Jpmorgan Chase & Co+899,757
- Morgan Stanley+898,323
- Qube Research & Technologies Ltd+880,714
- Franklin Templeton Inc+752,789
- Ameriprise Financial Inc+692,997
- FMR LLC+397,412
- Charles Schwab Investment Management Inc+369,100
Sold most
- State Street Corp−852,300
- Citadel Advisors LLC−717,917
- Goldman Sachs Group Inc−445,087
- Point72 Asset Management, L.P.−347,537
- Algert Global LLC−111,849
- D. E. Shaw & Co., Inc.−106,793
- BlackRock, Inc.−99,004
- Monashee Investment Management LLC−90,000
New positions (shares held)
- Ghisallo Capital Management LLC500,000
- Affinity Asset Advisors, LLC400,000
- Millennium Management LLC237,633
- HRT Financial LP118,384
- Squarepoint Ops LLC105,624
- Weiss Asset Management LP93,052
- Aquatic Capital Management LLC90,954
- Optimize Financial Inc.46,991
Insiders' open-market purchases (up) and sales (down), by quarter
Source: SEC Form 13F data sets and Forms 4 and 5. Institutions report three months after each quarter; a quarter's purchases and sales add up each institution's change since its report for the quarter before. Insiders' trades count open-market purchases and sales only, in the company's reporting currency. 131 mutual funds and ETFs hold Solid Biosciences Inc. in their latest reports: 24 new, 76 adding, 31 cutting.
128 funds held 21.2% of the company in their latest reports. Fund holdings are part of what their managers report on Form 13F, so do not add the two.
| Fund | Manager | Country | Of the company | Value | Report of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | The Vanguard Group, Inc. | 🇺🇸 | 2.82% | $31 M | Jun 30, 2026 |
| State Street SPDR S&P Biotech ETF | SSGA Funds Management, Inc. | 🇺🇸 | 2.31% | $26 M | Jun 30, 2026 |
| iShares Russell 2000 ETF | BlackRock Fund Advisors | 🇺🇸 | 1.84% | $21 M | Jun 30, 2026 |
| Select Biotechnology Portfolio | Fidelity Management & Research Company LLC | 🇺🇸 | 2.34% | $19 M | May 31, 2026 |
| Franklin Biotechnology Discovery Fund | Franklin Advisers, Inc. | 🇺🇸 | 1.26% | $11 M | Jul 31, 2026 |
Source: Fund portfolios filed with regulators (SEC Form N-PORT and others) · as of Jul 31, 2026
- Purchases
- 0
- Sales
- 28
- Bought
- $0 M
- Sold
- $3 M
Questions and answers#
Who owns Solid Biosciences Inc.?
Solid Biosciences Inc. is a listed company: its shares trade on Nasdaq, so it is owned by its shareholders. 158 institutional investors that report to the SEC on Form 13F held 106.5% of its shares on Sep 30, 2026. The largest of them was Ra Capital Management, L.P. with 10.78%, followed by Perceptive Advisors LLC (10.67%) and Bain Capital Life Sciences Investors, LLC (8.79%).
Who is the largest shareholder of Solid Biosciences Inc.?
Among investors that file SEC Form 13F, Ra Capital Management, L.P. was the largest on Sep 30, 2026, with 10.78% of the shares. Founders, executives and other people who hold shares in their own name report them on SEC Forms 3, 4 and 5 and in the proxy statement, not on Form 13F, so they are not in this ranking.
How much of Solid Biosciences Inc. do institutional investors own?
158 institutional investors that report to the SEC on Form 13F held 106.5% of its shares on Sep 30, 2026.
Which mutual funds own Solid Biosciences Inc.?
128 mutual funds held 21.2% of the company in their latest reports (the newest of Jul 31, 2026); the largest position was Vanguard Total Stock Market Index Fund's. Funds' holdings are part of what their managers report on Form 13F, so the two shares overlap.
Sources#
Every figure on this page comes from these, with the date shown next to it.
- SEC Form 13F holdings reports
- Fund portfolios filed with regulators (SEC Form N-PORT, Brazil CVM, Sweden Finansinspektionen, Indian fund houses)
- SEC Forms 3, 4 and 5 (insider transactions)